The pharmaceutical industry in Brazil is expected to grow at a CAGR of around 14% during 2010-2013, says RNCOS in its latest research study.
Online PR News – 08-June-2010 – – According to our new research report “Brazil Healthcare Market Analysis”, the pharmaceutical industry in Brazil has been continuously growing for the last few years although the concerns of high taxes on medicines present negative conditions. This strong growth could be attributed to the fact that the private players are making huge investments in this sector as Brazil has been graded as one of the most promising pharmerging countries across the world. Therefore, the future of this industry remains pleasantly buoyant with a CAGR of around 14% during 2010-2013.
We have done an extensive research and prudent analysis of the Brazilian pharmaceutical industry in order to understand the factors that will continue to serve as growth drivers over the forecast period (2010-2013). Several factors such as growing healthcare spending and the epidemiological transitions have been resulting into the strong demand for high-priced drugs and expensive therapies. Moreover, the soaring demand for primary health care level drugs such as generics, antibiotics and OTC drugs will drive the industry growth in coming years. Demand for generic and OTC drugs will inflate in Brazil, as a number of drugs will lose their patents. The report also gives an insight into the role of government in the regulation of pharmaceutical companies.
Our research indicates that the Brazilian healthcare industry shows immense growth potential and requires the attention of existing as well as new players. There is a high demand for hospitals services and experienced healthcare professionals. Besides, the country is highly dependent on imported drugs, thereby giving room to the private players to set up their own manufacturing capacities in the country. It also gives an overview of the factors that may hinder the healthcare industry growth in coming years.
Our report “Brazil Healthcare Market Analysis”" provides comprehensive information about the recent market trends, future growth scenario and authentic statistics for different segments of the Brazilian healthcare industry. The report has thoroughly examined industrial developments and competitive landscapes to enable clients understand the market structure and its progress in coming years.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM261.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.